subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:33118

subject_name: Boric acid

object_name: vulvovaginal candidiasis

tested_intervention: yes


subject: CHEBI:33118

object_name: diabetes mellitus


subject: UMLS:C0939844

subject_name: red clover preparation

object_name: Osteopenia


subject: UMLS:C0939844

object_name: osteoporosis


subject: UMLS:C0939844

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C0939844

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C0939844

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:63610

subject_name: Misoprostol

object_name: abortion; induced, nonmedical


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: cardiovascular disorder

tested_intervention: unsure


subject: CHEBI:6503

object_name: osteoarthritis


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:6904

subject_name: Metoprolol


subject: GTOPDB:11132

subject_name: otilimab

object_name: rheumatoid arthritis


subject: UNII:Y8127R3VCH

subject_name: Otilimab


subject: CHEBI:195559

subject_name: Poziotinib

object_name: Advanced Malignant Solid Neoplasm


subject: MESH:C557213


subject: UMLS:C5447526

subject_name: PARP/Microtubule Polymerization Inhibitor AMXI-5001

object_name: Advanced cancer


subject: UMLS:C5447526

object_name: Homologous Recombination Deficiency


subject: UMLS:C5447526

object_name: pancreatic neoplasm


subject: UMLS:C5447526

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5447526

object_name: malignant pancreatic neoplasm


subject: UMLS:C5447526

object_name: prostate carcinoma


subject: UMLS:C5447526

object_name: prostate cancer


subject: UMLS:C5447526

object_name: ovarian cancer


subject: UMLS:C5447526

object_name: ovarian neoplasm


subject: UMLS:C5447526

object_name: ovarian carcinoma


subject: UMLS:C5447526

object_name: Childhood Breast Carcinoma


subject: UMLS:C5447526

object_name: breast carcinoma


subject: UMLS:C5447526

object_name: breast cancer


subject: UMLS:C3827135

object_name: plasma cell myeloma


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Chronic hand eczema


subject: UMLS:C3658854


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Eosinophilic bronchitis


subject: UNII:90Z2UF0E52

object_name: Chronic cough


subject: CHEMBL.COMPOUND:CHEMBL4650290

object_name: adult glioblastoma


subject: UMLS:C3896855


subject: UNII:4X4HLN92OT

subject_name: Tribulus terrestris

object_name: Menopause present (finding)


subject: UNII:4X4HLN92OT

object_name: Menopause


subject: CHEBI:36791

subject_name: Escitalopram

object_name: social phobia


subject: PUBCHEM.COMPOUND:12043008

subject_name: Stribild

object_name: sleep disorder


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:36791

object_name: AIDS


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:149504

object_name: Hyperkalemia, CTCAE


subject: CHEBI:149504

object_name: Hyperkalemia


subject: CHEBI:149504

object_name: chronic kidney disease


subject: CHEBI:149504

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: UNII:1FQ2RY5YHH

subject_name: Patiromer


subject: UMLS:C5237268

subject_name: Gallium Ga 68 FAPi-46

object_name: Primary malignant neoplasm


subject: UMLS:C5237268

object_name: cancer


subject: UMLS:C5237268

object_name: neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Locally Advanced Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:63598

subject_name: Levofloxacin

object_name: endophthalmitis


subject: CHEBI:63598

object_name: Endophthalmitis, CTCAE


subject: CHEBI:62880

subject_name: Veliparib

object_name: ovarian epithelial tumor


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Shivering


subject: CHEBI:149520

subject_name: Polihexanide

object_name: Surgical Wound Infection


subject: CHEBI:139072

object_name: Treatment Resistant Disorders


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:71464

subject_name: Palmidrol

object_name: Prostatitis category III (National Institute of Health classification)


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: MESH:C000722721

subject_name: VLA2001 COVID-19 vaccine


subject: UMLS:C5442122

subject_name: VITAMIN B

object_name: hyperhomocysteinemia


subject: UMLS:C5442122

object_name: hyperlipoproteinemia


subject: UMLS:C1704763

subject_name: B Vitamin Family


subject: UMLS:C1704763


subject: CHEBI:75769

subject_name: B vitamin


subject: CHEBI:75769


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX


subject: CHEMBL.COMPOUND:CHEMBL2108015


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:6096882

object_name: peripheral arterial disease


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: heart failure


subject: UMLS:C1527137

object_name: Heart Failure, CTCAE


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:681850

subject_name: Conivaptan

object_name: ADHF


subject: GTOPDB:9297

subject_name: lutikizumab

object_name: Acne inversa


subject: CHEMBL.COMPOUND:CHEMBL4594518

subject_name: LUTIKIZUMAB


subject: UMLS:C5226856


subject: UNII:P050J5FWC5

subject_name: INTERFERON GAMMA

object_name: viral pneumonia


subject: UNII:P050J5FWC5

object_name: COVID-19 respiratory infection


subject: UMLS:C3468047

object_name: herpes zoster


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: diabetic retinopathy


subject: UMLS:C1313807


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Hyperketonemia


subject: CHEBI:85078

object_name: Ketosis


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: Childhood Craniopharyngioma


subject: MESH:D007651

subject_name: Keto Acids

object_name: Complication of hemodialysis


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Bone fracture


subject: UNII:4EQZ6YO2HI

object_name: Fracture, CTCAE


subject: UNII:4EQZ6YO2HI

object_name: end stage renal failure


subject: UNII:4EQZ6YO2HI

object_name: Chronic uremia


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: disorder; mental, sedative


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:44915

subject_name: Propofol


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Ewing sarcoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UMLS:C4745246

subject_name: Ozekibart


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:31355

subject_name: Carboplatin


subject: PUBCHEM.COMPOUND:444033

subject_name: Ciclesonide

object_name: Airway hyperresponsiveness


subject: PUBCHEM.COMPOUND:444033

object_name: respiratory system disorder


subject: CHEBI:4911

subject_name: Etoposide

object_name: primitive neuroectodermal tumor


subject: CHEBI:31355


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339

object_name: medulloblastoma


subject: CHEBI:82339

object_name: childhood medulloblastoma


subject: CHEBI:82339

object_name: adult medulloblastoma


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:9570

subject_name: Thiotepa


subject: UMLS:C4547427

subject_name: (18F)T807 compound

object_name: HIV infection


subject: PUBCHEM.COMPOUND:6420057

subject_name: METOPROLOL TARTRATE

object_name: myocardial ischemia


subject: CHEBI:55352

subject_name: (R)-Atenolol


subject: CHEBI:2904

subject_name: Atenolol


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: inflammatory bowel disease


subject: UMLS:C1172157


subject: UMLS:C1172157

object_name: ulcerative colitis


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Burn injury


subject: CHEBI:9241

subject_name: Spironolactone

object_name: hyperaldosteronism


subject: PUBCHEM.COMPOUND:76956344

subject_name: Legalon SIL

object_name: chronic hepatitis C virus infection


subject: CHEBI:172705

subject_name: DEHYDROSILYLBIN


subject: UNII:4RKY41TBTF

subject_name: SILIBININ


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: juvenile idiopathic arthritis


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Pathologic Neovascularization


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: solitary osseous plasmacytoma


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:6917964

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:6917964

object_name: Neoplasm Metastasis


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:7726


subject: PUBCHEM.COMPOUND:162640850

object_name: Solid Neoplasm


subject: UMLS:C5555505

subject_name: mTORC1 Kinase Inhibitor RMC-5552


subject: UNII:S6PL6DS4XK


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: ischemia


subject: CHEBI:16958

subject_name: beta-Alanine

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:16958

object_name: Fatigue


subject: UMLS:C0000392

subject_name: beta-alanine


subject: UMLS:C0000392


subject: CHEBI:30145

subject_name: lithium atom

object_name: Acute mania


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UNII:L1F3R18W77

subject_name: Asciminib

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: UNII:L1F3R18W77

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: UMLS:C3540703

subject_name: ANTIANDROGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM

object_name: prostate neoplasm


subject: CHEBI:35497

subject_name: androgen antagonist


subject: UMLS:C0002842

subject_name: Androgen Antagonists


subject: CHEBI:25812

subject_name: Ozone

object_name: Chronic pain


subject: GTOPDB:9110

object_name: prostate carcinoma


subject: GTOPDB:9110

object_name: prostate cancer


subject: GTOPDB:9110

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:64153

object_name: acute undifferentiated leukemia


subject: CHEBI:64153

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:64153

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:64153

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Duchenne muscular dystrophy


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:27732

subject_name: Caffeine

object_name: Reperfusion Injury


subject: CHEBI:27732

object_name: cardiovascular disorder


subject: CHEBI:3699

subject_name: Cimetidine

object_name: atopic eczema


subject: CHEBI:3699

object_name: IMMUNOGLOBULIN E CONCENTRATION, SERUM


subject: UMLS:C0972569

subject_name: Electrophoresis Gel

object_name: Xerostomia


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: CHEBI:4453

subject_name: Desogestrel

object_name: Abnormal uterine bleeding


subject: CHEBI:4453

object_name: Metrorrhagia


subject: CHEBI:50697

subject_name: minocycline hydrochloride

object_name: periodontitis


subject: DRUGBANK:DB17931

subject_name: Engensis

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: DRUGBANK:DB17931

object_name: amyotrophic lateral sclerosis


subject: CHEBI:60783

subject_name: nucleoside analogue

object_name: chronic hepatitis B virus infection


subject: UMLS:C3537141

subject_name: Nucleoside Analog [EPC]


subject: CHEBI:63610

subject_name: Misoprostol


subject: CHEBI:63610

object_name: Chronic pelvic pain of female


subject: CHEBI:63610

object_name: female infertility


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Stage III Esophageal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

subject_name: Carboplatin


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg

object_name: type C thymoma


subject: UMLS:C5434105

object_name: thymoma


subject: UMLS:C5434105

object_name: thymus neoplasm


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: CHEBI:33375

subject_name: Gadolinium

object_name: glioblastoma


subject: CHEBI:33375

object_name: Childhood Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEMBL.COMPOUND:CHEMBL1232993

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: diffuse glioma, H3 G34 mutant


subject: PUBCHEM.COMPOUND:1805

object_name: astrocytoma, IDH-mutant, grade 4


subject: PUBCHEM.COMPOUND:1805

object_name: Gliosarcoma of brain


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Inflammation


subject: CHEBI:119915

subject_name: Fentanyl

object_name: interstitial lung disease


subject: CHEBI:201756

subject_name: Clindamycin 2-Phosphate

object_name: vaginitis


subject: CHEBI:201756

object_name: vulvovaginitis


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:3745


subject: CHEBI:3240

subject_name: Butoconazole


subject: CHEBI:3240


subject: MESH:D003287

subject_name: Contrast Media

object_name: Gender


subject: CHEBI:91899

object_name: Poor quality sleep


subject: CHEBI:91899

object_name: emphysema


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:17026

subject_name: Progesterone

object_name: pregnancy disorder


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:151315

subject_name: Heparin

object_name: spinal stenosis


subject: CHEBI:151315

object_name: brain neoplasm


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: UMLS:C5556658

subject_name: B-Raf Inhibitor KIN-2787

object_name: Adult Solid Neoplasm


subject: UMLS:C5556658

object_name: non-small cell lung carcinoma


subject: UMLS:C5556658

object_name: melanoma


subject: PUBCHEM.COMPOUND:126481870

subject_name: valemetostat

object_name: liver carcinoma


subject: UNII:60RD0234VE

subject_name: Valemetostat


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Dry Eye, CTCAE


subject: CHEBI:6129

object_name: Dryness of eye


subject: HMDB:HMDB0033369

subject_name: Hydroxypropyl methylcellulose

object_name: dry eye syndrome


subject: HMDB:HMDB0033369


subject: HMDB:HMDB0033369


subject: UNII:B1QE5P712K

subject_name: hypromellose 2208 (100 MPA.S)


subject: UNII:B1QE5P712K


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:192614

object_name: metabolic syndrome X


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: UMLS:C5418770

subject_name: Oligo-fucoidan

object_name: Non-small cell lung cancer stage III


subject: UMLS:C5418770

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:2735

object_name: bone disorder


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:15365

subject_name: Aspirin

object_name: metastatic colorectal cancer


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Sedation complication


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:57389748

object_name: coronary atherosclerosis


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Non-small cell lung cancer recurrent


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Endocrine Breast Diseases


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:5523

subject_name: Goserelin


subject: UMLS:C0149473

subject_name: Zoladex


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Immune Tolerance


subject: CHEBI:22652

object_name: Drug Tolerance


subject: UNII:183E4W213W

subject_name: Calcium ascorbate dihydrate


subject: UNII:183E4W213W


subject: PUBCHEM.COMPOUND:76170378

subject_name: Calcium ascorbate


subject: PUBCHEM.COMPOUND:76170378


subject: UMLS:C1289969

subject_name: Phosphorus supplement

object_name: Dent disease


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: protein-losing enteropathy


subject: CHEBI:71940

subject_name: Tadalafil

object_name: acute respiratory distress syndrome


subject: UMLS:C5854562

subject_name: FRa/TRPV6 Bispecific Ligand-drug Conjugate CBP-1019

object_name: carcinoma of esophagus


subject: UMLS:C5854562

object_name: esophageal cancer


subject: UMLS:C5854562

object_name: pancreatic neoplasm


subject: UMLS:C5854562

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5854562

object_name: malignant pancreatic neoplasm


subject: UMLS:C5854562

object_name: colorectal cancer


subject: UMLS:C5854562

object_name: colorectal carcinoma


subject: UMLS:C5854562

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5854562

object_name: breast carcinoma


subject: UMLS:C5854562

object_name: breast cancer


subject: UMLS:C5854562

object_name: lung cancer


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: rectal carcinoma


subject: UNII:8M7YSN2KII

object_name: rectal cancer


subject: UNII:8M7YSN2KII

object_name: Childhood Rectal Carcinoma


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: MESH:C079198

subject_name: S 1 (combination)


subject: MESH:C079198


subject: MESH:C079198


subject: UMLS:C5690696

subject_name: MitoQ

object_name: coronary microvascular disorder


subject: UNII:K27MHH614O

subject_name: mitoquinol


subject: UNII:H8MTN7XVC2

subject_name: Mitometh

object_name: Carcinoma breast stage IV


subject: PR:000029794

subject_name: mitochondrial import inner membrane translocase subunit Tim8 A


subject: PUBCHEM.COMPOUND:17753757

subject_name: Pimecrolimus

object_name: Chapped lip


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: lesion; vascular, central nervous system


subject: PUBCHEM.COMPOUND:6096882

object_name: brain aneurysm


subject: PUBCHEM.COMPOUND:6096882

object_name: arteriovenous malformations of the brain


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:176724

subject_name: Etiracetam

object_name: hematologic disorder


subject: CHEBI:176724

object_name: immunodeficiency disease


subject: CHEBI:176724

object_name: inherited hemoglobinopathy


subject: CHEBI:176724

object_name: hemoglobinopathy


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:10112

subject_name: Zileuton

object_name: sickle cell disease


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: brain injury


subject: CHEBI:4910

subject_name: Etomidate

object_name: Difficult tracheal intubation (finding)


subject: CHEBI:6121

subject_name: Ketamine


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: graft versus host disease


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: retinal disease


subject: CHEBI:46195

object_name: Retinopathy


subject: CHEBI:46195

object_name: Retinopathy, CTCAE


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Unresectable Nasopharyngeal Carcinoma


subject: GTOPDB:9592

object_name: Nasopharyngeal cancer recurrent


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:85990

subject_name: Panobinostat

object_name: skin neoplasm


subject: CHEBI:85990

object_name: skin cancer


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: chronic rhinosinusitis


subject: CHEBI:9667

object_name: Rhinosinusitis


subject: PUBCHEM.COMPOUND:46883775

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Miller-Dieker lissencephaly syndrome


subject: PUBCHEM.COMPOUND:92043599

object_name: myoclonic dystonia 11


subject: CHEBI:9168

subject_name: Sirolimus

object_name: post-traumatic stress disorder


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:90948

subject_name: osimertinib mesylate

object_name: lung neoplasm


subject: UMLS:C2984503

subject_name: Urokinase-Derived Peptide A6

object_name: primary peritoneal carcinoma


subject: UMLS:C2984503

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C2984503

object_name: peritoneal carcinoma


subject: UMLS:C2984503

object_name: fallopian tube carcinoma


subject: UMLS:C2984503

object_name: Recurrent ovarian cancer


subject: UMLS:C2984503

object_name: Malignant Ovarian Mixed Epithelial Tumor


subject: UMLS:C2984503

object_name: ovarian seromucinous carcinoma


subject: UMLS:C2984503

object_name: undifferentiated ovarian carcinoma


subject: UMLS:C2984503

object_name: ovarian Brenner tumor


subject: UMLS:C2984503

object_name: ovarian clear cell cystadenocarcinoma


subject: UMLS:C2984503

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C2984503

object_name: ovarian serous cystadenocarcinoma


subject: UMLS:C2984503

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:17688

subject_name: Nicotine

object_name: Second hand tobacco smoke


subject: CHEBI:151

subject_name: ISOCITRIC ACID

object_name: non-small cell lung carcinoma


subject: CHEBI:151

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:7OSV6M6T4D

subject_name: ALNUCTAMAB

object_name: plasma cell myeloma


subject: UMLS:C5554526

subject_name: GS/pan-Notch Inhibitor AL102

object_name: fibromatosis


subject: UMLS:C5554526

object_name: desmoid tumor


subject: UMLS:C5554526

object_name: Desmoid tumor


subject: CHEBI:15365

subject_name: Aspirin

object_name: soft tissue neoplasm


subject: CHEBI:151315

subject_name: Heparin


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:133008

subject_name: Epclusa

object_name: end stage renal failure


subject: CHEBI:133008

object_name: Chronic uremia


subject: RXCUI:1799208

subject_name: sofosbuvir / velpatasvir Oral Product


subject: RXCUI:1799208


subject: CHEBI:41423

subject_name: Celecoxib

object_name: tonsillitis


subject: UMLS:C0282556

subject_name: Anti-Asthmatic Agents

object_name: chronic asthma


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Breast Cancer Lymphedema


subject: CHEBI:3215

object_name: Lymphedema of upper limb


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: pervasive developmental disorder


subject: CHEBI:166520

object_name: autism


subject: CHEBI:166520

object_name: autism spectrum disorder


subject: CHEBI:1391

subject_name: Midomafetamine


subject: CHEBI:1391


subject: CHEBI:1391


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: RXCUI:8375


subject: RXCUI:8375


subject: GTOPDB:11601

subject_name: olokizumab


subject: CHEMBL.COMPOUND:CHEMBL1743050

subject_name: OLOKIZUMAB


subject: UMLS:C3885146


subject: CHEBI:134966

subject_name: Rufinamide

object_name: Lennox-Gastaut syndrome


subject: UMLS:C5782157

subject_name: Medium-chain Triglyceride [EPC]

object_name: Premature infant


subject: UMLS:C5782157

object_name: candidiasis


subject: DRUGBANK:DB13959

subject_name: Medium-chain triglycerides


subject: DRUGBANK:DB13959


subject: PR:000010231

subject_name: malonyl-CoA-acyl carrier protein transacylase, mitochondrial


subject: PR:000010231


subject: PR:000022561

subject_name: malonyl CoA-acyl carrier protein transacylase


subject: PR:000022561


subject: PR:000023036


subject: PR:000023036


subject: UMLS:C3541397

subject_name: oil ingredients


subject: UMLS:C3541397


subject: MESH:D009821

subject_name: Oils


subject: MESH:D009821


subject: CHEBI:31859

subject_name: Modafinil

object_name: Somnolence


subject: CHEBI:31859

object_name: Hypopnea syndrome


subject: CHEBI:50663

subject_name: Zanamivir

object_name: Arthralgia


subject: CHEBI:50663

object_name: Arthralgia, CTCAE


subject: CHEBI:8673

subject_name: Pyrimethamine

object_name: Myelodysplasia


subject: CHEBI:8382

subject_name: Prednisone

object_name: glucose intolerance


subject: CHEBI:8382

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:8382

object_name: glucocorticoids toxicity


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: stage IV pancreatic cancer


subject: UNII:Y6BX7BL23K

object_name: Advanced Pancreatic Carcinoma


subject: UNII:Y6BX7BL23K

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: lumbar disc herniation


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: bile duct adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: gastric adenocarcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:53311

subject_name: sodium alginate

object_name: Gastrointestinal symptom


subject: PUBCHEM.COMPOUND:131704328

subject_name: Alginic acid


subject: CHEMBL.COMPOUND:CHEMBL2108744

subject_name: SODIUM ALGINATE


subject: CHEBI:50858

subject_name: corticosteroid

object_name: hemangioma


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:B72HH48FLU

object_name: COPD, severe early onset


subject: UNII:B72HH48FLU

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0033307

subject_name: Progestational Hormones, Synthetic

object_name: Androgen excess


subject: CHEBI:59826

subject_name: progestin


subject: UMLS:C3536710

subject_name: Progestin [EPC]


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:2735

object_name: adult acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:4305

subject_name: dacarbazine

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: CHEBI:4305

object_name: Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Hodgkin's lymphoma, lymphocytic-histiocytic predominance


subject: CHEBI:4305

object_name: Adult Lymphocyte-Rich Classical Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Childhood Nodular Sclerosis Classic Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: CHEBI:4305

object_name: nodular sclerosis classical Hodgkin lymphoma


subject: CHEBI:4305

object_name: Childhood Mixed Cellularity Classic Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Hodgkin's lymphoma, mixed cellularity


subject: CHEBI:4305

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate

object_name: Adult Classical Hodgkin Lymphoma


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: Pruritus


subject: UMLS:C0295415

subject_name: rituximab

object_name: Crouzon syndrome-acanthosis nigricans syndrome


subject: PUBCHEM.COMPOUND:607

subject_name: Adderall

object_name: Attention deficit-hyperactivity


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:75551

object_name: Parkinson disease


subject: UNII:19J3781LPM

object_name: hematologic disorder


subject: CHEBI:7421

subject_name: NAC

object_name: Rest limb pain


subject: CHEBI:7421

object_name: amputation of knee


subject: CHEBI:7421

object_name: diabetes mellitus


subject: CHEBI:7421

object_name: peripheral vascular disease


subject: CHEBI:7421

object_name: peripheral arterial disease


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: male breast carcinoma


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Advanced cancer


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:3175

subject_name: Brimonidine

object_name: myopia


subject: CHEBI:3175

object_name: 1/3 meter (distance vision finding)


subject: CHEBI:3175

object_name: Miosis


subject: CHEBI:3175

object_name: Constricted pupil (finding)


subject: CHEBI:151315

subject_name: Heparin

object_name: Diabetic foot ulcer


subject: CHEBI:151315

object_name: diabetic peripheral angiopathy


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight


subject: MESH:D006495


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: CHEBI:8382

subject_name: Prednisone

object_name: Pemphigoid


subject: CHEBI:45615

subject_name: Salicylhydroxamic Acid

object_name: male infertility


subject: CHEBI:45615

object_name: inability to impregnate


subject: CHEBI:229764

subject_name: Selinexor

object_name: primary central nervous system lymphoma


subject: UMLS:C0753357

subject_name: MultiHance

object_name: brain neoplasm


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Rotator Cuff Injuries


subject: CHEBI:5790

object_name: Rotator Cuff Injury, CTCAE


subject: UNII:9J13XU96Z1

subject_name: Azenosertib

object_name: Childhood Breast Carcinoma


subject: UNII:9J13XU96Z1

object_name: breast carcinoma


subject: UNII:9J13XU96Z1

object_name: breast cancer


subject: UNII:9J13XU96Z1

object_name: Her2-receptor negative breast cancer


subject: UNII:9J13XU96Z1

object_name: triple-negative breast carcinoma


subject: UNII:9J13XU96Z1

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:9J13XU96Z1

object_name: Malignant neoplasm of female breast


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: inflammatory bowel disease


subject: UMLS:C4054948

subject_name: Pegloprastide


subject: UMLS:C4054948

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C4054948

object_name: malignant neoplasm of breast stage I


subject: UMLS:C4054948

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C4054948

object_name: Carcinoma breast stage I


subject: UMLS:C4054948

object_name: Breast cancer stage II


subject: UMLS:C4054948

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C4054948

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C4054948

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C4054948

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C4054948

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C4054948

object_name: Breast cancer stage III


subject: UMLS:C4054948

object_name: Stage III Breast Cancer AJCC v6


subject: UMLS:C4054948

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C4054948

object_name: breast carcinoma


subject: UMLS:C4054948

object_name: primary invasive malignant neoplasm of female breast


subject: UMLS:C4054948

object_name: invasive ductal breast carcinoma


subject: UMLS:C4054948

object_name: breast ductal adenocarcinoma


subject: CHEBI:77590

subject_name: Armodafinil

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:31859

subject_name: Modafinil


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Hypomagnesemia


subject: UMLS:C3540792

object_name: Hypomagnesemia, CTCAE


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: limb ischemia


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: pediatric lymphoma


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: UMLS:C0282248

subject_name: Novantrone


subject: UMLS:C0282248


subject: UMLS:C0282248


subject: UMLS:C5552950

subject_name: Ciclopirox Prodrug CPX-POM

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: non-Hodgkin lymphoma


subject: CHEBI:3311


subject: CHEBI:3311


subject: CHEBI:3311


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: obstructive sleep apnea syndrome


subject: UNII:XQG9Q75WDN

subject_name: sodium pentaborate

object_name: nonpapillary renal cell carcinoma


subject: UNII:XQG9Q75WDN

object_name: clear cell renal carcinoma


subject: UNII:XQG9Q75WDN

object_name: renal cell adenocarcinoma


subject: UNII:XQG9Q75WDN

object_name: renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5314999

subject_name: SODIUM PENTABORATE


subject: CHEMBL.COMPOUND:CHEMBL5314999


subject: CHEMBL.COMPOUND:CHEMBL5314999


subject: CHEMBL.COMPOUND:CHEMBL5314999


subject: UNII:789Q85GA8P

subject_name: Vorasidenib

object_name: astrocytoma, IDH-mutant, grade 3


subject: UNII:XKF7EDC32B

object_name: HIV-1 infection


subject: UNII:6I3O3W6O3B

subject_name: Entospletinib

object_name: neoplasm


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor


subject: UMLS:C4039583


subject: UMLS:C4039583


subject: CHEBI:74705

subject_name: Met-Leu

object_name: deafness


subject: CHEBI:74705

object_name: hearing loss by exam


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: glioblastoma


subject: CHEBI:66919

object_name: Childhood Glioblastoma


subject: CHEBI:66919

object_name: adult glioblastoma


subject: CHEBI:66919

object_name: MGMT-Methylated Glioblastoma


subject: CHEBI:66919

object_name: Brain Stem Glioblastoma


subject: CHEBI:66919

object_name: glioma susceptibility 1


subject: CHEBI:66919

object_name: MGMT-Unmethylated Glioblastoma


subject: CHEBI:66919

object_name: brain glioblastoma


subject: CHEBI:66919

object_name: brain cancer


subject: CHEBI:66919

object_name: brain neoplasm


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: mycosis fungoides


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Peptic Ulcer


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Stomach cancer


subject: CHEBI:50275

object_name: gastric cancer


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Heart Failure, CTCAE


subject: UMLS:C0030956

subject_name: Peptides

object_name: Malignant neoplasm of female breast


subject: PR:000018264

subject_name: proteolytic cleavage product


subject: UMLS:C0312555

subject_name: Neoantigen


subject: PUBCHEM.COMPOUND:6433115

subject_name: reparixin

object_name: Reperfusion Injury


subject: UNII:95D580798S

subject_name: Picosulfuric acid

object_name: colon adenoma


subject: UNII:95D580798S

object_name: colorectal cancer


subject: UNII:95D580798S

object_name: colorectal carcinoma


subject: UNII:95D580798S

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:131389

subject_name: magnesium citrate


subject: CHEBI:131389


subject: CHEBI:131389


subject: CHEBI:131389


subject: CHEBI:131391


subject: CHEBI:131391


subject: CHEBI:131391


subject: CHEBI:131391


subject: UNII:CV8JZR21A1

subject_name: Dipraglurant

object_name: blepharospasm


subject: UNII:CV8JZR21A1

object_name: dystonia


subject: PUBCHEM.COMPOUND:75905632

subject_name: flavocoxid

object_name: Duchenne muscular dystrophy


subject: CHEMBL.COMPOUND:CHEMBL5095276

subject_name: FLAVOCOXID


subject: UMLS:C1616742


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: cryptococcosis


subject: CHEBI:46081

subject_name: Fluconazole


subject: DRUGBANK:DB05014

object_name: plasma cell myeloma


subject: UMLS:C3884847

subject_name: ma zi ren wan

object_name: cancer


subject: UMLS:C3884847

object_name: neoplasm


subject: CHEBI:28171

object_name: mood (physical finding)


subject: CHEBI:17780

subject_name: Oxitriptan


subject: UMLS:C3536964

subject_name: rotavirus, live, tetravalent vaccine

object_name: Safety Issues


subject: UNII:5C44M1QYCC

object_name: migraine


subject: UNII:MLU3LU3EVV

subject_name: Onasemnogene abeparvovec

object_name: spinal muscular atrophy, type II


subject: UNII:MLU3LU3EVV

object_name: spinal muscular atrophy, type III


subject: UNII:MLU3LU3EVV

object_name: Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma


subject: UMLS:C5140521

subject_name: onasemnogene abeparvovec-xioi


subject: UMLS:C5140521


subject: UMLS:C5140521


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Childhood Overweight


subject: PUBCHEM.COMPOUND:18772499

object_name: Pediatric Obesity


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: CHEMBL.COMPOUND:CHEMBL4650292

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C3827106


subject: CHEBI:74088

object_name: HER2 positive breast carcinoma


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody


subject: MESH:C408069

subject_name: BIII 890 CL

object_name: stroke disorder


subject: MESH:C408069

object_name: cerebrovascular disorder


subject: MESH:C408069

object_name: Stroke (heart beat)


subject: MESH:C408069

object_name: Stroke, CTCAE


subject: UMLS:C5187967

subject_name: Spiriva HandiHaler

object_name: COPD, severe early onset


subject: UMLS:C5187967

object_name: chronic obstructive pulmonary disease


subject: CHEBI:85995

subject_name: lenvatinib mesylate

object_name: metastatic melanoma


subject: UMLS:C2606791


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: cancer


subject: PUBCHEM.COMPOUND:6427057

object_name: neoplasm


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: PR:000013574

subject_name: sulfhydryl oxidase 1

object_name: neuroendocrine carcinoma


subject: UMLS:C3467922


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: microscopic polyangiitis


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UMLS:C1831957


subject: UMLS:C1831957


subject: UMLS:C5847498

subject_name: Irinotecan liposome injection


subject: UMLS:C5847498


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: habitual spontaneous abortion


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:16811

subject_name: Racemethionine

object_name: autoimmune pulmonary alveolar proteinosis


subject: CHEBI:16811

object_name: pulmonary alveolar proteinosis


subject: UMLS:C0034504

subject_name: racemethionine


subject: UMLS:C0034504


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: CHEBI:73824

subject_name: Asn-Glu

object_name: Hemorrhagic Shock


subject: CHEBI:33310

subject_name: Neon


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Rest limb pain


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:135905

subject_name: Terlipressin

object_name: Hepatorenal syndrome type 1


subject: GTOPDB:8323

subject_name: monalizumab

object_name: Non-small cell lung cancer stage III


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: GTOPDB:9596

subject_name: oleclumab


subject: UNII:5CRY01URYQ

subject_name: OLECLUMAB


subject: UMLS:C4085967

subject_name: Oleclumab


subject: UMLS:C0754326

subject_name: Optison

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0754326

object_name: clear cell renal carcinoma


subject: UMLS:C0754326

object_name: renal cell adenocarcinoma


subject: UMLS:C0754326

object_name: renal cell carcinoma


subject: CHEBI:188719

subject_name: Ertugliflozin

object_name: Congestion


subject: CHEBI:188719

object_name: Tissue Congestion


subject: UMLS:C0796480

subject_name: Monoclonal Antibody HeFi-1

object_name: neoplasm


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:31348

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:135445

subject_name: Canrenone

object_name: heart failure


subject: CHEBI:135445

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:319260

subject_name: Phanurane


subject: PUBCHEM.COMPOUND:319260


subject: CHEBI:67271

object_name: Gallbladder cancer stage II


subject: CHEBI:67271

object_name: Stage II Gallbladder Cancer AJCC v6


subject: CHEBI:67271

object_name: Stage II Gallbladder Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage II Gallbladder Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:67271

object_name: stage IVA gallbladder cancer


subject: CHEBI:67271

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:67271

object_name: stage IIIA gallbladder cancer


subject: CHEBI:67271

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: CHEBI:67271

object_name: gallbladder adenocarcinoma


subject: CHEBI:67271

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:67271

object_name: metastatic extrahepatic bile duct cancer


subject: CHEBI:67271

object_name: adenocarcinoma of gallbladder with squamous metaplasia


subject: CHEBI:67271

object_name: advanced adult primary liver cancer


subject: CHEBI:67271

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: CHEBI:67271

object_name: cholangiocarcinoma


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Gallbladder cancer stage II


subject: CHEBI:90227

object_name: Stage II Gallbladder Cancer AJCC v6


subject: CHEBI:90227

object_name: Stage II Gallbladder Cancer AJCC v8


subject: CHEBI:90227

object_name: Stage II Gallbladder Cancer AJCC v7


subject: CHEBI:90227

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: CHEBI:90227

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:90227

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: CHEBI:90227

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:90227

object_name: stage IVA gallbladder cancer


subject: CHEBI:90227

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:90227

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:90227

object_name: stage IIIA gallbladder cancer


subject: CHEBI:90227

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:90227

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: CHEBI:90227

object_name: gallbladder adenocarcinoma


subject: CHEBI:90227

object_name: metastatic extrahepatic bile duct cancer


subject: CHEBI:90227

object_name: adenocarcinoma of gallbladder with squamous metaplasia


subject: CHEBI:90227

object_name: advanced adult primary liver cancer


subject: CHEBI:90227

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: CHEBI:90227

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:90227

object_name: Recurrent Adult Liver Carcinoma


subject: GTOPDB:8313

subject_name: talazoparib

object_name: fallopian tube carcinoma


subject: GTOPDB:8313

object_name: fallopian tube cancer


subject: GTOPDB:8313

object_name: High grade serous carcinoma


subject: CHEBI:38215

subject_name: calcium channel blocker

object_name: coronary atherosclerosis


subject: UMLS:C0006684

subject_name: Calcium Channel Blockers


subject: CHEBI:31247

subject_name: Azelnidipine

object_name: coronary artery disorder


subject: CHEBI:31247


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: metastatic colorectal cancer


subject: GTOPDB:12347

subject_name: penpulimab


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: CHEBI:177298

object_name: malignant neoplasm of ovary stage IV


subject: CHEBI:176844

subject_name: Niraparib


subject: UNII:L26E95NLRK

subject_name: CUSTIRSEN

object_name: non-small cell lung carcinoma


subject: CHEBI:32712

subject_name: L-tryptophanyl radical

object_name: rectal carcinoma


subject: CHEBI:32712

object_name: rectal cancer


subject: CHEBI:32712

object_name: Childhood Rectal Carcinoma


subject: CHEBI:32712

object_name: Childhood Breast Carcinoma


subject: CHEBI:32712

object_name: breast carcinoma


subject: CHEBI:32712

object_name: breast cancer


subject: CHEBI:32712

object_name: neuroendocrine neoplasm


subject: CHEBI:32712

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:32712

object_name: Intracranial glioma


subject: CHEBI:29954

subject_name: L-tryptophan residue


subject: CHEBI:29954


subject: CHEBI:29954


subject: CHEBI:29954


subject: CHEBI:29954


subject: CHEBI:29954


subject: CHEBI:29954


subject: CHEBI:29954


subject: CHEBI:29954


subject: CHEBI:27897

subject_name: tryptophan


subject: CHEBI:27897


subject: CHEBI:27897


subject: CHEBI:27897


subject: CHEBI:27897


subject: CHEBI:27897


subject: CHEBI:27897


subject: CHEBI:27897


subject: CHEBI:27897


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: colitis


subject: UNII:I031V2H011

object_name: Colitis, CTCAE


subject: UNII:I031V2H011

object_name: arthritis


subject: UNII:I031V2H011

object_name: Arthritis, CTCAE


subject: UNII:I031V2H011

object_name: Childhood Solid Neoplasm


subject: UNII:I031V2H011

object_name: Adult Solid Neoplasm


subject: CHEBI:33325

subject_name: radium atom

object_name: plasma cell myeloma


subject: UMLS:C3827153


subject: UMLS:C4048552


subject: UMLS:C4048552


subject: UMLS:C4048552


subject: CHEBI:231614

subject_name: Nivolumab

object_name: endometrium neoplasm


subject: UMLS:C2346820


subject: CHEBI:60799

subject_name: Esketamine

object_name: Burn injury


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Acne inversa


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: sarcomatoid renal cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: chromophobe renal cell carcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:242911

object_name: migraine with aura


subject: UMLS:C4305840


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: Mutation Abnormality


subject: CHEBI:77562

object_name: Stage III Lung Cancer


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:75045


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: UNII:7DR7JMB8BH


subject: UNII:7DR7JMB8BH


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: UNII:SMA5ZS5B22


subject: PUBCHEM.COMPOUND:157827766

subject_name: GLECIRASIB


subject: PUBCHEM.COMPOUND:157827766


subject: DRUGBANK:DB18744

subject_name: Glecirasib


subject: DRUGBANK:DB18744


subject: UNII:PF9462I9HX

subject_name: Larotrectinib


subject: UNII:PF9462I9HX


subject: UNII:1WPE73O1WV

subject_name: PRALSETINIB


subject: UNII:1WPE73O1WV


subject: CHEMBL.COMPOUND:CHEMBL4582651

subject_name: Pralsetinib


subject: CHEMBL.COMPOUND:CHEMBL4582651


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: UNII:CJN36EQM0H


subject: CHEBI:231369

subject_name: Savolitinib


subject: CHEBI:231369


subject: UNII:L1Q2K5JYO8

subject_name: SUNVOZERTINIB


subject: UNII:L1Q2K5JYO8


subject: DRUGBANK:DB18925

subject_name: Sunvozertinib


subject: DRUGBANK:DB18925


subject: UMLS:C0017853

subject_name: Hemoglobin, Glycosylated

object_name: type 1 diabetes mellitus


subject: UMLS:C0019018

subject_name: Glycosylated hemoglobin A


subject: PUBCHEM.COMPOUND:9834332

subject_name: Brivaracetam

object_name: focal epilepsy


subject: UMLS:C5401612

subject_name: Recombinant human plasma gelsolin

object_name: Community-Acquired Pneumonia


subject: CHEBI:18332

subject_name: Levothyroxine

object_name: trisomy 21


subject: UMLS:C4762501

subject_name: Tirosint-Sol

object_name: hypothyroidism


subject: UMLS:C4762501

object_name: Hypothyroidism, CTCAE


subject: UMLS:C4762501


subject: UMLS:C4762501

object_name: Down syndrome


subject: CHEBI:94556

subject_name: Nifuroxazide

object_name: inflammatory bowel disease


subject: UMLS:C4058551

subject_name: Paliperidone ER

object_name: pervasive developmental disorder


subject: UMLS:C4058551

object_name: autism


subject: CHEBI:184023

subject_name: Argininosuccinic acid

object_name: cerebrovascular disorder


subject: CHEBI:184023

object_name: Acute Stroke


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:15365

subject_name: Aspirin


subject: PR:000004321

subject_name: arylsulfatase A


subject: PR:000004321


subject: CHEBI:74947

subject_name: Thalidomide

object_name: endometrial cancer


subject: CHEBI:74947

object_name: uterine corpus cancer


subject: CHEBI:74947

object_name: endometrial carcinoma


subject: PR:000001015

subject_name: receptor-type tyrosine-protein phosphatase C isoform CD45RA

object_name: acute leukemia


subject: PR:000001015

object_name: acute leukemia in relapse


subject: PR:000001015

object_name: Refractory Acute Leukemia


subject: PR:000001015

object_name: adult acute myeloid leukemia


subject: PR:000001015

object_name: childhood acute myeloid leukemia


subject: PR:000001015

object_name: acute myeloid leukemia


subject: UMLS:C0108789

subject_name: CD45RA Antigens


subject: UMLS:C0108789


subject: UMLS:C0108789


subject: UMLS:C0108789


subject: UMLS:C0108789


subject: UMLS:C0108789


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: iron deficiency anemia


subject: UMLS:C3714803

object_name: Iron deficiency


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:46217

subject_name: L-alanine residue

object_name: acute kidney failure


subject: CHEBI:46217

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:32433

subject_name: L-alanyl group


subject: CHEBI:32433


subject: CHEBI:17061

subject_name: D-Glutamine


subject: CHEBI:17061


subject: CHEBI:30011

subject_name: L-glutamine residue


subject: CHEBI:30011


subject: CHEBI:6413

subject_name: Letrozole

object_name: Polycystic ovary syndrome of bilateral ovaries


subject: CHEBI:9168

subject_name: Sirolimus

object_name: hepatobiliary disorder


subject: CHEBI:9168

object_name: liver disorder


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Epiphysiolysis


subject: CHEBI:2666

subject_name: Amitriptyline


subject: CHEBI:4975

subject_name: Famotidine

object_name: Childhood Breast Carcinoma


subject: CHEBI:4975

object_name: breast carcinoma


subject: CHEBI:4975

object_name: breast cancer


subject: CHEBI:4975

object_name: Filgrastim adverse reaction


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:194135

subject_name: Ofloxacin

object_name: myopia


subject: CHEBI:194135

object_name: Ametropia


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:73678


subject: CHEBI:73678


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:28864


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: UMLS:C4079949

object_name: liver carcinoma


subject: UMLS:C4733657

subject_name: ADC BA3021

object_name: melanoma


subject: UMLS:C4733657

object_name: triple-negative breast carcinoma


subject: UMLS:C4733657

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4733657

object_name: non-small cell lung carcinoma


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: CHEBI:132922

object_name: Pain Relief


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Zygomycosis


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Metastatic urothelial carcinoma


subject: CHEBI:231005

object_name: Locally Advanced Urothelial Carcinoma


subject: CHEBI:231005

object_name: Advanced Urothelial Carcinoma


subject: CHEBI:231005

object_name: Urothelial carcinoma recurrent


subject: CHEBI:231005

object_name: Unresectable Urothelial Carcinoma


subject: CHEBI:231005

object_name: Bladder transitional cell carcinoma stage III


subject: CHEBI:231005

object_name: Bladder transitional cell carcinoma stage IV


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:45716

object_name: Recurrent Glioblastoma


subject: CHEBI:176381

subject_name: Diosmin

object_name: Vinca alkaloid adverse reaction


subject: CHEBI:61606


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin


subject: CHEBI:6538


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: pancreatic ductal adenocarcinoma


subject: UNII:4Z63YK6E0E

object_name: Refractory Lung Non-Small Cell Carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:Z41TGB4080

subject_name: Eprenetapopt

object_name: Mantle cell lymphoma refractory


subject: UNII:Z41TGB4080

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C5447987

subject_name: eprenetapopt


subject: UMLS:C5447987


subject: UMLS:C0304547

subject_name: Lactobacillus acidophilus preparation

object_name: cervical lymphadenitis


subject: UMLS:C0304547

object_name: canker sore


subject: UMLS:C0304547

object_name: Minor oral aphthous ulceration


subject: UMLS:C0304547

object_name: aphthous stomatitis


subject: UMLS:C0304547

object_name: pharyngitis


subject: UMLS:C0304547

object_name: Pharyngitis, CTCAE


subject: UMLS:C0304547

object_name: Periodic fever


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEBI:2611

subject_name: Alprazolam

object_name: social phobia


subject: CHEBI:144094

subject_name: bicalutamide

object_name: High Risk Prostate Carcinoma


subject: CHEBI:144094

object_name: Localized Prostate Adenocarcinoma


subject: CHEBI:144094

object_name: Stage II Prostate Cancer AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Stage I Prostate Cancer AJCC v8


subject: UNII:DPT0O3T46P


subject: UMLS:C0919077

subject_name: Sirolimus, oral, 1 mg

object_name: coronary restenosis


subject: UMLS:C0919077

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: anemia


subject: PUBCHEM.COMPOUND:2735

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: CHEBI:73558

subject_name: D3 vitamins


subject: CHEBI:73558


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: UNII:71M78END5S


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: UNII:J6K8WSV73A

subject_name: Quemliclustat

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: UNII:J6K8WSV73A

object_name: Locally Advanced Pancreatic Ductal Adenocarcinoma


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: PUBCHEM.COMPOUND:90331177

object_name: Neoplasm Metastasis


subject: UMLS:C3896889

subject_name: ERK Inhibitor CC-90003


subject: CHEBI:3175

subject_name: Brimonidine

object_name: pterygium


subject: CHEBI:3175

object_name: conjunctival pterygium


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Locally Advanced Clear Cell Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:18772499

object_name: Clear-cell metastatic renal cell carcinoma


subject: PUBCHEM.COMPOUND:18772499

object_name: Stage III Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:18772499

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:18772499

object_name: Locally Advanced Sarcomatoid Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:18772499

object_name: Metastatic Sarcomatoid Renal Cell Carcinoma


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:231324

subject_name: alpelisib

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]

object_name: Her2-receptor negative breast cancer


subject: UMLS:C3536820


subject: UMLS:C4287766

object_name: Malignant melanoma of skin of breast


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: idiopathic inflammatory myopathy


subject: PUBCHEM.COMPOUND:65404

subject_name: fanasil, pyrimethamine drug combination

object_name: Anemia in children


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine


subject: UMLS:C5226842

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C5226842

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:121488170

subject_name: Pegvorhyaluronidase Alfa

object_name: pancreatic ductal adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL3989976

subject_name: PEGVORHYALURONIDASE ALFA


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: systemic mastocytosis


subject: CHEBI:91397

object_name: aggressive systemic mastocytosis


subject: CHEBI:91397

object_name: mast cell leukemia


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Adhesive Capsulitis


subject: CHEBI:6456

object_name: frozen shoulder


subject: CHEBI:6456

object_name: bursitis


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: Voice tremor


subject: UNII:7CND0TX59N

object_name: Vocal tremor


subject: CHEBI:25646

subject_name: octanoate


subject: CHEBI:25646


subject: CHEBI:28837

subject_name: Caprylic acid


subject: CHEBI:28837


subject: MESH:C570015

subject_name: 4CMenB vaccine

object_name: meningococcal infection


subject: MESH:C570015

object_name: Premature infant


subject: MESH:C570015

object_name: Premature birth


subject: DRUGBANK:DB10510

subject_name: Brazil nut

object_name: mild neurocognitive disorder


subject: DRUGBANK:DB10510

object_name: mild cognitive impairment


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: HMDB:HMDB0001349


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: Failed attempted abortion


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: traumatic encephalopathy


subject: CHEBI:26710

object_name: traumatic brain injury


subject: UMLS:C5854614

subject_name: BCR Signaling Pathway Inhibitor DZD8586

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5854614

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C5854614

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:22972

subject_name: butyryl group


subject: CHEBI:22972


subject: CHEBI:22972


subject: CHEBI:22927

subject_name: bromine atom


subject: CHEBI:22927


subject: CHEBI:22927


subject: CHEBI:22925

subject_name: bromide salt


subject: CHEBI:22925


subject: CHEBI:22925


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Malignant Solid Neoplasm


subject: UMLS:C2984028

subject_name: Docetaxel-PNP

object_name: Childhood Solid Neoplasm


subject: UMLS:C2984028

object_name: Adult Solid Neoplasm


subject: UMLS:C2984028

object_name: Solid Neoplasm


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: Unresectable Hepatocellular Carcinoma


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: CHEBI:15552

subject_name: Epoprostenol

object_name: Acute pulmonary embolism


subject: UMLS:C1701590

object_name: AIDS


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Breast neoplasm female


subject: UNII:V038D626IF

subject_name: Ashwagandha

object_name: Menopause present (finding)


subject: UNII:V038D626IF

object_name: Menopause


subject: UNII:V038D626IF

object_name: Hot Flashes, CTCAE


subject: UNII:V038D626IF

object_name: Hot flashes


subject: UNII:V038D626IF

object_name: mood (physical finding)


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: Secondary Central Nervous System Lymphoma


subject: UNII:D6OMY2L0WA

object_name: Refractory Central Nervous System Lymphoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: PUBCHEM.COMPOUND:85048876

subject_name: Atripla

object_name: HIV infection


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:137706467

object_name: Diamond-Blackfan anemia


subject: PUBCHEM.COMPOUND:137706467

object_name: Fanconi anemia


subject: PUBCHEM.COMPOUND:137706467

object_name: Fanconi anemia complementation group A


subject: PUBCHEM.COMPOUND:137706467

object_name: thalassemia


subject: CHEBI:7009

subject_name: Moxonidine

object_name: Androgen excess


subject: MESH:C476037

subject_name: PHY 906

object_name: pancreatic neoplasm


subject: MESH:C476037

object_name: exocrine pancreatic carcinoma


subject: MESH:C476037

object_name: malignant pancreatic neoplasm


subject: GTOPDB:4985

object_name: Unresectable Melanoma


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: metastatic melanoma


subject: UMLS:C4086713


subject: CHEBI:8673

subject_name: Pyrimethamine

object_name: familial amyotrophic lateral sclerosis


subject: CHEBI:490877

subject_name: Didanosine


subject: KEGG.COMPOUND:C00471

subject_name: Plasmin

object_name: peripheral vascular disease


subject: UMLS:C0016016

subject_name: plasmin


subject: CHEBI:75551


subject: CHEBI:52763


subject: CHEBI:15891

subject_name: Taurine

object_name: pervasive developmental disorder


subject: CHEBI:15891

object_name: autism


subject: CHEBI:15891

object_name: autism spectrum disorder


subject: UMLS:C5445313

subject_name: Corn starch antigen


subject: UMLS:C5445313


subject: UMLS:C5445313


subject: DRUGBANK:DB11599

subject_name: Starch, corn


subject: DRUGBANK:DB11599


subject: DRUGBANK:DB11599


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:17992


subject: CHEBI:17992


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: multiple organ dysfunction syndrome


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: ST-elevation myocardial infarction


subject: CHEBI:32660

subject_name: asparaginase

object_name: extranodal nasal NK/T cell lymphoma


subject: UMLS:C4527229

subject_name: Anti-ASCT2 Antibody-drug Conjugate MEDI7247

object_name: plasma cell myeloma


subject: UMLS:C4527229

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4527229

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C4527229

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C4527229

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4527229

object_name: acute myeloid leukemia


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: preeclampsia


subject: CHEBI:38290

object_name: eclampsia


subject: CHEBI:38290

object_name: Pregnant


subject: CHEBI:38290

object_name: HELLP syndrome


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C2827125

subject_name: davalintide

object_name: Overweight


subject: UMLS:C2827125

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C2827125

object_name: obesity


subject: UMLS:C2827125

object_name: Obesity, CTCAE


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: premenstrual tension


subject: MESH:D002136

object_name: polydactyly-myopia syndrome


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: PUBCHEM.COMPOUND:3962

object_name: arteriovenous malformations of the brain


subject: CHEBI:40303

subject_name: Lovastatin


subject: UNII:PTN9LJL6PY

object_name: psoriasis


subject: CHEBI:32090

subject_name: Rebamipide

object_name: Sicca Syndrome


subject: CHEBI:91398

subject_name: Tivantinib

object_name: small cell carcinoma


subject: CHEBI:94534

subject_name: olanzapine

object_name: inherited lipid metabolism disorder


subject: CHEBI:94534

object_name: Dyslipidemia


subject: UMLS:C5963450

object_name: Solid Neoplasm


subject: UMLS:C5963450

object_name: neoplasm


subject: CHEBI:72296

subject_name: Apixaban

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: CHEBI:72296

object_name: Poisoning by, adverse effect of and underdosing of anticoagulants


subject: CHEBI:72296

object_name: Poisoning by anticoagulant


subject: UMLS:C2703210

object_name: plasma cell myeloma


subject: UMLS:C2703210

object_name: lung cancer


subject: UMLS:C2703210

object_name: lung neoplasm


subject: UMLS:C2703210

object_name: lung carcinoma


subject: UMLS:C2703210

object_name: ovarian cancer


subject: UMLS:C2703210

object_name: ovarian neoplasm


subject: UMLS:C2703210

object_name: ovarian carcinoma


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: allergic asthma


subject: UMLS:C3658854


subject: UMLS:C5565156


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: Shivering


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB

object_name: colorectal cancer


subject: UNII:OX5LRQ5H6K

object_name: colorectal carcinoma


subject: UNII:OX5LRQ5H6K

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4329332

subject_name: Fianlimab


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4687663

object_name: Childhood Breast Carcinoma


subject: UMLS:C4687663

object_name: breast carcinoma


subject: UMLS:C4687663

object_name: breast cancer


subject: UMLS:C5667026

subject_name: Hpk1 Inhibitor PRJ1-3024

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:17051

subject_name: Fluoride ion

object_name: Tooth problem


subject: CHEBI:88316

subject_name: Nefopam

object_name: Dysesthesia


subject: CHEBI:88316

object_name: chronic pain syndrome


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Metastatic Malignant Solid Neoplasm


subject: MESH:D003069

subject_name: Coffee

object_name: Obstipation


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: light chain deposition disease


subject: CHEMBL.COMPOUND:CHEMBL1237024

subject_name: SIPULEUCEL-T

object_name: hormone-resistant prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1237024

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEMBL.COMPOUND:CHEMBL1237024

object_name: Carcinoma of the prostate stage IV


subject: CHEMBL.COMPOUND:CHEMBL1237024

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL1237024

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL1237024

object_name: Prostate cancer recurrent


subject: CHEBI:231355

subject_name: Tasquinimod


subject: CHEBI:231355


subject: CHEBI:231355


subject: CHEBI:231355


subject: CHEBI:231355


subject: CHEBI:231355

object_name: metastatic prostate carcinoma


subject: CHEBI:231355


subject: CHEBI:73611

subject_name: Met-Gly

object_name: Weight Gain


subject: CHEBI:73611

object_name: Weight Gain, CTCAE


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Mixed urinary incontinence


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Stress urinary incontinence


subject: UMLS:C1962503

subject_name: Seroquel XR

object_name: schizophrenia


subject: CHEBI:6541

subject_name: Losartan

object_name: Oral Mucositis


subject: CHEBI:6541

object_name: stomatitis


subject: CHEBI:6541

object_name: oral mucositis


subject: CHEBI:6541

object_name: Intestinal mucositis


subject: CHEBI:6541

object_name: colorectal cancer


subject: CHEBI:6541

object_name: colorectal carcinoma


subject: CHEBI:6541

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2703095

object_name: mouth neoplasm


subject: CHEBI:75998

subject_name: Trametinib


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: diabetes mellitus


subject: UNII:Q40Q9N063P

subject_name: ACETIC ACID

object_name: Skin ulcer


subject: CHEBI:40410

subject_name: N-acetylglycine


subject: UMLS:C1550049

subject_name: Acetic Acid - Specimen Additive


subject: UMLS:C0000985

subject_name: Acetic Acids


subject: CHEBI:15366

subject_name: Acetic acid


subject: UMLS:C1948065

subject_name: ZIO 201

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:16143379

subject_name: Human epidermal growth factor

object_name: periodontitis


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: plasma cell myeloma


subject: UMLS:C1948073


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: end stage renal failure


subject: CHEBI:35176

object_name: Chronic uremia


subject: CHEBI:50733

subject_name: nutraceutical

object_name: gestational diabetes


subject: CHEBI:50733

object_name: inherited lipid metabolism disorder


subject: CHEBI:50733

object_name: glucose metabolism disease


subject: CHEBI:50733

object_name: Insulin resistance


subject: CHEBI:31891

subject_name: Naftopidil

object_name: hyperplasia


subject: CHEBI:31891

object_name: Hyperplasia of the endometrium


subject: CHEBI:132922

object_name: Light for dates


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: PUBCHEM.COMPOUND:40703

subject_name: PINAVERIUM BROMIDE

object_name: cancer


subject: PUBCHEM.COMPOUND:40703

object_name: neoplasm


subject: UNII:7SCF54H12J

subject_name: Pinaverium bromide [MI]


subject: UNII:7SCF54H12J


subject: CHEBI:135811

subject_name: Pinaverium


subject: CHEBI:135811


subject: UMLS:C4743011

object_name: inflammatory disease


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545

object_name: Autoimmunity


subject: CHEBI:73788

subject_name: Ala-Gln

object_name: colon carcinoma


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Postoperative shivering


subject: CHEBI:5613

subject_name: Haloperidol

object_name: gastroparesis


subject: CHEBI:5613

object_name: Gastroparesis, CTCAE


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: Chronic hepatitis


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: UMLS:C4745024

subject_name: EGFR Antisense DNA BB-401

object_name: head and neck squamous cell carcinoma


subject: CHEBI:84500

subject_name: varenicline

object_name: cannabis abuse


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: eosinophilic fasciitis


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: kidney failure


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:3757

subject_name: Clonidine

object_name: anxiety


subject: CHEBI:3757

object_name: anxiety disorder


subject: CHEBI:3757

object_name: Anxiety symptoms


subject: CHEBI:3757

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:3757

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:75331

subject_name: benzotriazole

object_name: interstitial cystitis


subject: CHEBI:75331

object_name: Painful Bladder Syndrome


subject: UMLS:C0676494

subject_name: bladder tumor-associated antigen


subject: UMLS:C0676494


subject: UMLS:C2587183

subject_name: RiaSTAP

object_name: Afibrinogenemia


subject: UMLS:C2587183

object_name: Fibrinogen Deficiency


subject: UMLS:C2587183

object_name: Hypofibrinogenemia


subject: UMLS:C2587183

object_name: Abnormal bleeding


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: lip and oral cavity carcinoma


subject: UMLS:C4086713

object_name: oral cavity cancer


subject: UNII:Z9U2SS9ZC8

object_name: liver carcinoma


subject: UMLS:C2703165


subject: CHEMBL.COMPOUND:CHEMBL5095294

subject_name: TEROPAVIMAB

object_name: HIV infection


subject: UMLS:C5669575

subject_name: Teropavimab


subject: UNII:L98LJF15I9

subject_name: ZINLIRVIMAB


subject: PUBCHEM.COMPOUND:16208013

subject_name: Tecemotide

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:16208013

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:16208013

object_name: Childhood Rectal Carcinoma


subject: UNII:Q7Y026G2CX

subject_name: TECEMOTIDE


subject: UNII:Q7Y026G2CX


subject: UNII:Q7Y026G2CX


subject: UMLS:C1832016


subject: UMLS:C1832016


subject: CHEBI:165821

subject_name: CpA


subject: CHEBI:165821


subject: CHEBI:165821


subject: UMLS:C5235864

subject_name: Voxalatamab

object_name: neoplasm


subject: UMLS:C0282575

subject_name: Micronutrients

object_name: Child Malnutrition


subject: UMLS:C0282575

object_name: Breast Feeding, Exclusive


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: exotropia


subject: CHEBI:3160

object_name: esotropia


subject: CHEBI:31593

subject_name: fasudil hydrochloride

object_name: carotid stenosis


subject: CHEBI:43871

subject_name: Fasudil


subject: UMLS:C0526099


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Mechanical ventilation finding


subject: DRUGBANK:DB19288

subject_name: Ophiocordyceps sinensis

object_name: glomerulonephritis


subject: DRUGBANK:DB19288

object_name: Chronic kidney disease stage 3B


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:4026

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:4026

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: Metastatic non-small cell lung cancer


subject: UNII:25E79B5CTM

object_name: Non-small cell lung cancer recurrent


subject: UNII:25E79B5CTM

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:25E79B5CTM

object_name: Carcinoma breast stage IV


subject: UNII:25E79B5CTM

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:25E79B5CTM

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:25E79B5CTM

object_name: Breast cancer recurrent


subject: UNII:25E79B5CTM

object_name: HER2 positive breast carcinoma


subject: UNII:25E79B5CTM


subject: UNII:25E79B5CTM


subject: UNII:25E79B5CTM


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: CHEBI:50932

subject_name: Chlorprothixene

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:50932

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:50932

object_name: morbid obesity


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Contrast media reaction


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: pain agnosia


subject: RXCUI:8375

object_name: Pain insensitivity


subject: UMLS:C2742210

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C2742210

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIA Breast Carcinoma


subject: UMLS:C2742210

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IIB Breast Carcinoma


subject: UMLS:C2742210

object_name: malignant neoplasm of breast stage IIb


subject: UMLS:C1443151

subject_name: Gum arabic antigen

object_name: sickle cell disease


subject: MESH:D006170

subject_name: Gum Arabic


subject: UNII:1YTW0422YU

subject_name: Gum arabic


subject: UMLS:C2093618

subject_name: arabic gum allergenic extract


subject: DRUGBANK:DB10451

subject_name: Acacia


subject: UMLS:C3474497

subject_name: AXONA

object_name: amyotrophic lateral sclerosis


subject: CHEBI:76978

subject_name: Tricaprylin


subject: CHEBI:8426

subject_name: Probenecid

object_name: influenza


subject: UMLS:C5446868

subject_name: Abiraterone Amorphous Solid Dispersion Formulation DST-2970

object_name: prostate carcinoma


subject: UMLS:C5446868

object_name: prostate cancer


subject: CHEBI:35341

subject_name: steroid

object_name: type 2 diabetes mellitus


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:95165

object_name: Primary malignant neoplasm


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Premature Labor


subject: CHEBI:8452

subject_name: Proflavine

object_name: mouth disorder


subject: CHEBI:8452

object_name: Premalignant Lesion


subject: CHEBI:8452

object_name: lip and oral cavity carcinoma


subject: CHEBI:8452

object_name: dysplasia


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: stroke disorder


subject: CHEBI:8228

object_name: cerebrovascular disorder


subject: CHEBI:8228

object_name: Stroke (heart beat)


subject: CHEBI:8228

object_name: Stroke, CTCAE


subject: UNII:S276568KOY

subject_name: Gadopiclenol

object_name: IMAGe syndrome


subject: PR:000016801

subject_name: transthyretin

object_name: amyloidosis, hereditary systemic 1


subject: PR:000016801

object_name: familial amyloid neuropathy


subject: PR:000016801

object_name: ATTR Amyloidosis


subject: PR:000016801

object_name: Cardiac amyloidosis


subject: PR:000016801

object_name: Transthyretin amyloid cardiomyopathy


subject: PR:000016801

object_name: Hereditary Transthyretin Amyloidosis with Polyneuropathy


subject: CHEBI:179553

subject_name: Hexyl 2-methylpropanoate

object_name: bacterial vaginosis


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UMLS:C0694951

subject_name: INJECTION, AMPHOTERICIN B, 50 MG ADMINISTERED


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:3242

subject_name: butorphanol

object_name: Agitation, CTCAE 3.0


subject: CHEBI:3242

object_name: Agitation


subject: CHEBI:3242

object_name: Agitation, CTCAE 5.0


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether

object_name: venous insufficiency


subject: PUBCHEM.COMPOUND:2724258

subject_name: Polyethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:76459

subject_name: Heptaethylene glycol monododecyl ether


subject: CHEBI:31765

subject_name: Laureth 4


subject: UMLS:C1263450

subject_name: lauromacrogols


subject: DRUGBANK:DB16899

subject_name: Hydromethylthionine mesylate

object_name: behavioral variant of frontotemporal dementia


subject: DRUGBANK:DB16899

object_name: Alzheimer disease


subject: UNII:C5529G5JPQ

subject_name: ginger extract

object_name: asthma


subject: UMLS:C3661302

subject_name: Infanrix hexa

object_name: Rotavirus infection


subject: UMLS:C3252923

subject_name: synflorix


subject: CHEBI:73461

subject_name: Cys-Pro

object_name: shigellosis


subject: CHEBI:30663

subject_name: cyclopentadienyl group


subject: CHEBI:17698

subject_name: Chloramphenicol


subject: CHEBI:16486

subject_name: cyclopentanone


subject: CHEBI:3380

subject_name: Captopril


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: AIDS


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:80961

object_name: carcinoma of esophagus


subject: CHEBI:80961

object_name: esophageal cancer


subject: CHEBI:80961

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:80961

object_name: neoplasm of esophagus


subject: CHEBI:176724

subject_name: Etiracetam

object_name: panic disorder


subject: CHEBI:176724

object_name: panic disorder 1


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:23965

subject_name: estradiol

object_name: Varicose Ulcer


subject: CHEBI:23965

object_name: varicose ulcer


subject: CHEBI:23965

object_name: Physical trauma


subject: CHEBI:23965

object_name: Injury


subject: CHEBI:23965

object_name: Trauma


subject: CHEBI:23965

object_name: Burn injury


subject: CHEBI:23965

object_name: Burn, CTCAE


subject: CHEBI:74808

subject_name: Ser-Gln

object_name: hematologic disorder


subject: PUBCHEM.COMPOUND:21285386

subject_name: SQ


subject: CHEBI:71219

subject_name: Pazopanib

object_name: prostate adenocarcinoma


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Liquid Tumor


subject: UNII:M89N0Q7EQR

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:M89N0Q7EQR

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:M89N0Q7EQR

object_name: Myelodysplasia


subject: UNII:M89N0Q7EQR

object_name: acute lymphoblastic leukemia


subject: PR:000001379


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: UMLS:C0016018

subject_name: Fibrinolytic Agents

object_name: myocardial infarction


subject: UMLS:C0016018

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C0016018

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0016018

object_name: atrial fibrillation


subject: UMLS:C0016018

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C0016018

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C0016018

object_name: coronary artery disorder


subject: UMLS:C0016018

object_name: Anticoagulant-induced bleeding


subject: UMLS:C1704311

subject_name: Antithrombotic Agents


subject: UMLS:C1704311


subject: UMLS:C1704311


subject: UMLS:C1704311


subject: UMLS:C1704311


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Graft versus host disease in eye


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C2934919

object_name: Fabry disease


subject: UMLS:C1617352

subject_name: INJECTION, PACLITAXEL PROTEIN-BOUND PARTICLES, 1 MG

object_name: pancreatic neoplasm


subject: UMLS:C1617352

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1617352

object_name: malignant pancreatic neoplasm


subject: CHEBI:84500

subject_name: varenicline

object_name: Cigarette smoker (finding)


subject: UNII:4W3KFI3TN3

subject_name: Talquetamab

object_name: Plasma cell myeloma recurrent


subject: UMLS:C4687984

subject_name: talquetamab


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: Blood Clot


subject: PUBCHEM.COMPOUND:135512673

object_name: thrombosis


subject: PUBCHEM.COMPOUND:135512673

object_name: Thrombosis of blood vessel


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: metastatic prostate carcinoma


subject: MESH:C000627770

subject_name: folfirinox

object_name: cholangiocarcinoma


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:131168

subject_name: Afuresertib

object_name: Langerhans cell histiocytosis


subject: CHEBI:131168

object_name: Langerhans cell histiocytosis specific to childhood


subject: CHEBI:131168

object_name: Langerhans cell histiocytosis specific to adulthood


subject: GTOPDB:6749

subject_name: fibrinogen

object_name: Childhood Hodgkin Lymphoma


subject: KEGG.COMPOUND:C00393

subject_name: Fibrinogen


subject: UMLS:C3540039

subject_name: Fibrinogen containing hemostatics


subject: UMLS:C2587184

subject_name: Parenogen


subject: UMLS:C0016006


subject: UMLS:C4087030

object_name: schizophrenia


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: congenital heart disease


subject: UMLS:C0911014

subject_name: ghrelin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0911014

object_name: obesity


subject: UMLS:C0911014

object_name: Obesity, CTCAE


subject: CHEBI:63607

subject_name: Linezolid

object_name: staphylococcal infection


subject: UMLS:C4086017

subject_name: BTK Inhibitor

object_name: Mantle cell lymphoma refractory


subject: UMLS:C4086017

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:231350

subject_name: Pacritinib


subject: CHEBI:231350


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: cancer


subject: MESH:C532412


subject: CHEBI:143079

subject_name: D-Leucine

object_name: Childhood atopic dermatitis


subject: UMLS:C3542918

subject_name: Docetaxel Lipid Microspheres


subject: UMLS:C3154117

object_name: influenza


subject: UNII:JTZ51LIXN4

subject_name: NEMTABRUTINIB

object_name: neoplasm of mature B-cells


subject: DRUGBANK:DB18866

subject_name: Nemtabrutinib


subject: CHEBI:17992

subject_name: Sucrose

object_name: congenital alveolar dysplasia


subject: CHEBI:17992

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:17992

object_name: adult acute respiratory distress syndrome


subject: CHEBI:17992

object_name: newborn respiratory distress syndrome


subject: CHEBI:15365

subject_name: Aspirin

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:15365

object_name: Embolism, Tumor


subject: CHEBI:15365

object_name: Neoplasm Metastasis


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:9637

subject_name: Torasemide

object_name: Edema


subject: UMLS:C1384659

object_name: carcinoma


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:75551

object_name: lung cancer


subject: CHEBI:75551

object_name: lung neoplasm


subject: CHEBI:75551

object_name: lung carcinoma


subject: CHEBI:75551


subject: CHEBI:6402

subject_name: Leflunomide

object_name: immunoglobulin G4-related sclerosing disease


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:91826462

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:91826462

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:91826462

object_name: neoplasm of esophagus


subject: CHEBI:31632

subject_name: Decasodium salt

object_name: cardiovascular disorder


subject: UMLS:C1145196

subject_name: INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED


subject: CHEBI:61033

subject_name: Fondaparinux


subject: PUBCHEM.COMPOUND:3367

object_name: lymphocyte count


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: nutritional supplement toxicity